Wanbangde Pharmaceutical Holding Group Co., Ltd. (002082.SZ)
CNY 7.0
(-2.51%)
CNY 7.0
(-2.51%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 26.99 Million CNY | -89.93% |
| 2022 | 268.05 Million CNY | -47.71% |
| 2021 | 512.68 Million CNY | -0.1% |
| 2020 | 513.21 Million CNY | 95.07% |
| 2019 | 263.1 Million CNY | 80.14% |
| 2018 | 146.05 Million CNY | 24.93% |
| 2017 | 116.91 Million CNY | 50.57% |
| 2016 | 77.64 Million CNY | -3.94% |
| 2015 | 80.82 Million CNY | -38.95% |
| 2014 | 132.4 Million CNY | -4.79% |
| 2013 | 139.05 Million CNY | 26.41% |
| 2012 | 110 Million CNY | -45.07% |
| 2011 | 200.24 Million CNY | 3.35% |
| 2010 | 193.76 Million CNY | 27.66% |
| 2009 | 151.77 Million CNY | 58.66% |
| 2008 | 95.66 Million CNY | 10.48% |
| 2007 | 86.58 Million CNY | 51.2% |
| 2006 | 57.26 Million CNY | 99.61% |
| 2005 | 28.68 Million CNY | -27.98% |
| 2004 | 39.83 Million CNY | 28.72% |
| 2003 | 30.94 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 16.03 Million CNY | 326.26% |
| 2024 Q2 | -7.08 Million CNY | -122.52% |
| 2024 Q1 | 31.46 Million CNY | -29.39% |
| 2023 Q1 | 24.18 Million CNY | 176.64% |
| 2023 Q2 | 2.52 Million CNY | -89.56% |
| 2023 Q3 | -44.27 Million CNY | -1853.84% |
| 2023 Q4 | 44.56 Million CNY | 200.65% |
| 2023 FY | 26.99 Million CNY | -89.93% |
| 2022 Q2 | 67.54 Million CNY | 141.4% |
| 2022 FY | 268.05 Million CNY | -47.71% |
| 2022 Q3 | 141.02 Million CNY | 108.79% |
| 2022 Q4 | -31.55 Million CNY | -122.38% |
| 2022 Q1 | 27.98 Million CNY | 88.27% |
| 2021 FY | 512.68 Million CNY | -0.1% |
| 2021 Q1 | 196.49 Million CNY | 3.93% |
| 2021 Q2 | 91.27 Million CNY | -53.55% |
| 2021 Q3 | 72.52 Million CNY | -20.54% |
| 2021 Q4 | 14.86 Million CNY | -79.51% |
| 2020 Q3 | 4.03 Million CNY | -95.48% |
| 2020 Q4 | 189.06 Million CNY | 4580.95% |
| 2020 Q1 | 64.09 Million CNY | -52.02% |
| 2020 Q2 | 89.4 Million CNY | 39.5% |
| 2020 FY | 513.21 Million CNY | 95.07% |
| 2019 Q4 | 133.57 Million CNY | 189.32% |
| 2019 Q1 | 19.23 Million CNY | -63.59% |
| 2019 Q2 | 64.12 Million CNY | 233.32% |
| 2019 Q3 | 46.16 Million CNY | -28.0% |
| 2019 FY | 263.1 Million CNY | 80.14% |
| 2018 Q3 | 34.46 Million CNY | -20.83% |
| 2018 Q4 | 52.83 Million CNY | 53.29% |
| 2018 FY | 146.05 Million CNY | 24.93% |
| 2018 Q1 | 15.23 Million CNY | -69.63% |
| 2018 Q2 | 43.53 Million CNY | 185.81% |
| 2017 Q3 | 32.59 Million CNY | 27.25% |
| 2017 Q2 | 25.61 Million CNY | 200.0% |
| 2017 Q1 | 8.53 Million CNY | -40.59% |
| 2017 FY | 116.91 Million CNY | 50.57% |
| 2017 Q4 | 50.15 Million CNY | 53.85% |
| 2016 Q1 | 10.34 Million CNY | 694.77% |
| 2016 FY | 77.64 Million CNY | -3.94% |
| 2016 Q4 | 14.37 Million CNY | -26.82% |
| 2016 Q3 | 19.64 Million CNY | -40.98% |
| 2016 Q2 | 33.28 Million CNY | 221.61% |
| 2015 Q4 | -1.73 Million CNY | -106.81% |
| 2015 Q1 | 11.22 Million CNY | -70.55% |
| 2015 FY | 80.82 Million CNY | -38.95% |
| 2015 Q2 | 45.8 Million CNY | 308.02% |
| 2015 Q3 | 25.54 Million CNY | -44.24% |
| 2014 FY | 132.4 Million CNY | -4.79% |
| 2014 Q3 | 28.85 Million CNY | -31.56% |
| 2014 Q1 | 23.27 Million CNY | -51.59% |
| 2014 Q4 | 38.11 Million CNY | 32.13% |
| 2014 Q2 | 42.15 Million CNY | 81.11% |
| 2013 Q3 | 28.4 Million CNY | -35.91% |
| 2013 Q1 | 18.25 Million CNY | -40.42% |
| 2013 Q2 | 44.31 Million CNY | 142.78% |
| 2013 Q4 | 48.08 Million CNY | 69.28% |
| 2013 FY | 139.05 Million CNY | 26.41% |
| 2012 FY | 110 Million CNY | -45.07% |
| 2012 Q3 | 19.52 Million CNY | -49.75% |
| 2012 Q2 | 38.86 Million CNY | 85.25% |
| 2012 Q1 | 20.97 Million CNY | -42.1% |
| 2012 Q4 | 30.63 Million CNY | 56.87% |
| 2011 Q1 | 41.18 Million CNY | -30.74% |
| 2011 FY | 200.24 Million CNY | 3.35% |
| 2011 Q2 | 71.86 Million CNY | 74.5% |
| 2011 Q4 | 36.23 Million CNY | -28.91% |
| 2011 Q3 | 50.96 Million CNY | -29.07% |
| 2010 Q2 | 52.06 Million CNY | 76.88% |
| 2010 Q4 | 59.46 Million CNY | 12.61% |
| 2010 Q1 | 29.43 Million CNY | -39.8% |
| 2010 Q3 | 52.8 Million CNY | 1.43% |
| 2010 FY | 193.76 Million CNY | 27.66% |
| 2009 FY | 151.77 Million CNY | 58.66% |
| 2009 Q4 | 48.88 Million CNY | 0.17% |
| 2009 Q3 | 48.8 Million CNY | 17.31% |
| 2009 Q2 | 41.6 Million CNY | 233.29% |
| 2009 Q1 | 12.48 Million CNY | -14.46% |
| 2008 FY | 95.66 Million CNY | 10.48% |
| 2008 Q3 | 30.57 Million CNY | -11.6% |
| 2008 Q1 | 15.91 Million CNY | -49.38% |
| 2008 Q2 | 34.58 Million CNY | 117.25% |
| 2008 Q4 | 14.59 Million CNY | -52.27% |
| 2007 Q2 | 22.83 Million CNY | 115.36% |
| 2007 Q4 | 31.44 Million CNY | 44.9% |
| 2007 Q1 | 10.6 Million CNY | -48.86% |
| 2007 FY | 86.58 Million CNY | 51.2% |
| 2007 Q3 | 21.7 Million CNY | -4.94% |
| 2006 Q4 | 20.73 Million CNY | 34.14% |
| 2006 Q3 | 15.45 Million CNY | -15.03% |
| 2006 Q2 | 18.18 Million CNY | 529.58% |
| 2006 Q1 | 2.88 Million CNY | -65.01% |
| 2006 FY | 57.26 Million CNY | 99.61% |
| 2005 Q3 | 4.45 Million CNY | 0.0% |
| 2005 Q4 | 8.25 Million CNY | 85.42% |
| 2005 FY | 28.68 Million CNY | -27.98% |
| 2004 FY | 39.83 Million CNY | 28.72% |
| 2003 FY | 30.94 Million CNY | 0.0% |